nach oben

Indian Journal of Otolaryngology and Head & Neck Surgery

Erschienen in:

28.03.2023 | Other Articles

Management of Recurrent Aphthous Stomatitis: An Indian Expert Consensus

verfasst von: Samir Bhargava, Satya Prakash Dubey, Deepak Haldipur, Bachi Hathiram, Charuhas Jagtap, Vicky Khattar, Shriram Vasant Kulkarni, Ashwin Kotamkar, Parthasarathy Muralidharan, Pradeep Kumar, Amit Qamra, Abhishek Ramadhin, Sreenivasan Venkatraman

Erschienen in: Indian Journal of Otolaryngology and Head & Neck Surgery | Ausgabe 3/2023

Einloggen, um Zugang zu erhalten

Abstract

Recurrent aphthous stomatitis (RAS) is characterized by painful, oral mucosal ulcers with wide range of prevalence ranging from 2 to 78%. Etiology of RAS is idiopathic and multifactorial. There are numerous gaps in assessment and management of RAS and the absence of guidelines or a consensus document makes the treatment further difficult. The aim of this document is to provide an Indian expert consensus for management of RAS. Experts from different specialties such as Otorhinolaryngology, Oral Medicine/Dentistry and Internal Medicine from India were invited for face to face and online meetings. After a deliberate discussion of current literature, evidence and clinical practice during advisory meetings, experts developed a consensus for management of RAS. We identify that the prevalence of RAS may lie between 2 and 5%. In defining RAS, we advocate three or more recurrences of aphthous ulcers per year as criterion for RAS. Investigation should include basic hematological (complete blood count) and nutritional (serum vitamin B12, and iron studies) parameters. Primary aim of treatment is to reduce the pain, accelerate ulcer healing, reduce the recurrences and improve the quality of life. In treating RAS, initial choice of medications is determined by pain intensity, number and size of ulcers and previous number of recurrences. Topical and systemic agents can be used in combination for effective relief. In conclusion, this consensus will help physicians and may harmonize effective diagnosis and treatment of RAS.

Tarakji B, Gazal G, Al-Maweri SA, Azzeghaiby SN, Alaizari N (2015) Guideline for the diagnosis and treatment of recurrent aphthous stomatitis for dental practitioners. J Int Oral Health 7:74–80PubMedPubMedCentral

Mirowski GW, Rosengard HC, Messadi DV (2020) What is the global prevalence of aphthous stomatitis (canker sore)? https://www.medscape.com/answers/1075570-61400/what-is-the-global-prevalence-of-aphthous-stomatitis-canker-sore Accessed 20 May 2022

Bhatnagar P, Rai S, Bhatnagar G, Kaur M, Goel S, Prabhat M (2013) Prevalence study of oral mucosal lesions, mucosal variants, and treatment required for patients reporting to a dental school in North India: in accordance with WHO guidelines. J Family Community Med 20:41–48. https://doi.org/10.4103/2230-8229.108183CrossRefPubMedPubMedCentral

Patil S, Reddy SN, Maheshwari S, Khandelwal S, Shruthi D, Doni B (2014) Prevalence of recurrent aphthous ulceration in the indian Population. J Clin Exp Dent 6:e36–40. https://doi.org/10.4317/jced.51227CrossRefPubMedPubMedCentral

Rao AK, Vundavalli S, Sirisha NR, Jayasree CH, Sindhura G, Radhika D (2015) The association between psychological stress and recurrent aphthous stomatitis among medical and dental student cohorts in an educational setup in India. J Indian Assoc Public Health Dent 13:133–137. https://www.jiaphd.org/text.asp?2015/13/2/133/159047CrossRef

Queiroz SIML, Silva MVAD, Medeiros AMC et al (2018) Recurrent aphthous ulceration: an epidemiological study of etiological factors, treatment and differential diagnosis. An Bras Dermatol 93:341–346. https://doi.org/10.1590/abd1806-4841.20186228CrossRefPubMedPubMedCentral

Xu K, Zhou C, Huang F et al (2021) Relationship between dietary factors and recurrent aphthous stomatitis in China: a cross-sectional study. J Int Med Res 49:03000605211017724. https://doi.org/10.1177/03000605211017724CrossRefPubMedPubMedCentral

Challacombe SJ, Alsahaf S, Tappuni A (2015) Recurrent aphthous stomatitis: towards evidence-based treatment? Curr Oral Health Rep 2:158–167. https://doi.org/10.1007/s40496-015-0054-yCrossRef

Porter SR, Scully C, Pedersen A, Recurrent aphthous stomatitis (1998) Crit Rev Oral Biol Med 9:306–321. https://doi.org/10.1177/10454411980090030401CrossRefPubMed

10.

Thoppay JR (2020) Aphthous Ulcers Clinical Presentation. Available from https://emedicine.medscape.com/article/867080-clinical Accessed on 20 May 2022

11.

Preeti L, Magesh K, Rajkumar K, Karthik R (2011) Recurrent aphthous stomatitis. J Oral Maxillofac Pathol 15:252–256. https://doi.org/10.4103/0973-029X.86669CrossRefPubMedPubMedCentral

12.

Shi L, Wan K, Tan M et al (2015) Risk factors of recurrent aphthous ulceration among university students. Int J Clin Exp Med 8:6218–6223PubMedPubMedCentral

13.

Zain RB (2000) Oral recurrent aphthous ulcers/stomatitis: prevalence in Malaysia and an epidemiological update. J Oral Sci 42:15–19. https://doi.org/10.2334/josnusd.42.15CrossRefPubMed

14.

Maheswaran T, Yamunadevi A, Ilayaraja V et al (2015) Correlation between the menstrual cycle and the onset of recurrent aphthous stomatitis. J Indian Acad Dent Spec Res 2:25–26. https://doi.org/10.4103/2229-3019.166117CrossRef

15.

Rajmane YR, Ashwinirani SR, Suragimath G et al (2017) Prevalence of recurrent aphthous stomatitis in western population of Maharashtra, India. J Oral Res Rev 9:25–28. https://doi.org/10.4103/jorr.jorr_33_16CrossRef

16.

Kaur R, Behl AB, Punia RS, Nirav K, Singh KB, Kaur S (2021) Assessment of Prevalence of Recurrent Aphthous Stomatitis in the North Indian Population: a cross-sectional study. J Pharm Bioallied Sci 13:S363–S366. https://doi.org/10.4103/jpbs.jpbs_581_20CrossRefPubMedPubMedCentral

17.

Akintoye SO, Greenberg MS (2014 Apr) Recurrent aphthous stomatitis. Dent Clin North Am. 58:281–. https://doi.org/10.1016/j.cden.2013.12.002. 2 97

18.

Wardhana, Datau EA (2010) Recurrent aphthous stomatitis caused by food allergy. Acta Med Indones 42:236–240PubMed

19.

Wright A, Ryan FP, Willingham SE et al (1986) Food allergy or intolerance in severe recurrent aphthous ulceration of the mouth. Br Med J (Clin Res Ed) 292:1237–1238. https://doi.org/10.1136/bmj.292.6530.1237CrossRefPubMed

20.

Sari RK, Ernawati DS, Soebadi B (2019) Recurrent aphthous stomatitis related to psychological stress, food allergy and GERD. ODONTO: Dent J 6:45–51. https://doi.org/10.30659/odj.6.0.45-51CrossRef

21.

Du Q, Ni S, Fu Y, Liu S (2018) Analysis of Dietary related factors of recurrent aphthous stomatitis among College Students. Evid Based Complement Alternat Med 27:2907812. https://doi.org/10.1155/2018/2907812CrossRef

22.

Koybasi S, Parlak AH, Serin E, Yilmaz F, Serin D (2006) Recurrent aphthous stomatitis: investigation of possible etiologic factors. Am J Otolaryngol 27:229–232. https://doi.org/10.1016/j.amjoto.2005.09.022CrossRefPubMed

23.

Chiang CP, Yu-Fong Chang J et al (2019) Recurrent aphthous stomatitis - etiology, serum autoantibodies, anemia, hematinic deficiencies, and management. J Formos Med Assoc 118:1279–1289. https://doi.org/10.1016/j.jfma.2018.10.023CrossRefPubMed

24.

Yıldırımyan N, Özalp Ö, Şatır S, Altay MA, Sindel A (2019) Recurrent Aphthous Stomatitis as a result of Zinc Deficiency. Oral Health Prev Dent 17:465–468. https://doi.org/10.3290/j.ohpd.a42736CrossRefPubMed

25.

Al-Maweri SA, Halboub E, Al-Sharani HM et al (2021) Association between serum zinc levels and recurrent aphthous stomatitis: a meta-analysis with trial sequential analysis. Clin Oral Investig 25:407–415. https://doi.org/10.1007/s00784-020-03704-8CrossRefPubMed

26.

Ozturk P, Belge Kurutas E, Ataseven A (2013) Copper/zinc and copper/selenium ratios, and oxidative stress as biochemical markers in recurrent aphthous stomatitis. J Trace Elem Med Biol 27:312–316. https://doi.org/10.1016/j.jtemb.2013.04.002CrossRefPubMed

27.

Shim YJ, Choi JH, Ahn HJ, Kwon JS (2012) Effect of sodium lauryl sulfate on recurrent aphthous stomatitis: a randomized controlled clinical trial. Oral Dis 18:655–660. https://doi.org/10.1111/j.1601-0825.2012.01920.xCrossRefPubMed

28.

Saxen MA, Ambrosius WT, Rehemtula al-KF, Russell AL, Eckert GJ (1997) Sustained relief of oral aphthous ulcer pain from topical diclofenac in hyaluronan: a randomized, double-blind clinical trial. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 84:356–361. https://doi.org/10.1016/s1079-2104(97)90031-7CrossRefPubMed

29.

Altenburg A, El-Haj N, Micheli C, Puttkammer M, Abdel-Naser MB, Zouboulis CC (2014) The treatment of chronic recurrent oral aphthous ulcers. Dtsch Arztebl Int 111:665–673. https://doi.org/10.3238/arztebl.2014.0665CrossRefPubMedPubMedCentral

30.

Bhat S, Sujatha D (2013) A clinical evaluation of 5% amlexanox oral paste in the treatment of minor recurrent aphthous ulcers and comparison with the placebo paste: a randomized, vehicle controlled, parallel, single center clinical trial. Indian J Dent Res 24:593–598. https://doi.org/10.4103/0970-9290.123382CrossRefPubMed

31.

Meng W, Dong Y, Liu J et al (2009) A clinical evaluation of amlexanox oral adhesive pellicles in the treatment of recurrent aphthous stomatitis and comparison with amlexanox oral tablets: a randomized, placebo controlled, blinded, multicenter clinical trial. Trials 10:30. https://doi.org/10.1186/1745-6215-10-30CrossRefPubMedPubMedCentral

32.

Skulason S, Holbrook WP, Kristmundsdottir T (2009) Clinical assessment of the effect of a matrix metalloproteinase inhibitor on aphthous ulcers. Acta Odontol Scand 67:25–29. https://doi.org/10.1080/00016350802526559CrossRefPubMed

33.

Al-Maweri SA, Halboub E, Ashraf S et al (2020) Single application of topical doxycycline in management of recurrent aphthous stomatitis: a systematic review and meta-analysis of the available evidence. BMC Oral Health 20:231. https://doi.org/10.1186/s12903-020-01220-5CrossRefPubMedPubMedCentral

34.

Belenguer-Guallar I, Jiménez-Soriano Y, Claramunt-Lozano A (2014) Treatment of recurrent aphthous stomatitis. A literature review. J Clin Exp Dent. Apr 1;6(2):e168-74. doi: https://doi.org/10.4317/jced.51401

35.

Quijano D, Rodríguez M (2008) Topical corticosteroids in recurrent aphthous stomatitis. Systematic review. Acta Otorrinolaringol Esp 59:298–307CrossRefPubMed

36.

Liu C, Zhou Z, Liu G et al (2012) Efficacy and safety of dexamethasone ointment on recurrent aphthous ulceration. Am J Med 125:292–301. https://doi.org/10.1016/j.amjmed.2011.09.011CrossRefPubMed

37.

Descroix V, Coudert AE, Vigé A et al (2011) Efficacy of topical 1% lidocaine in the symptomatic treatment of pain associated with oral mucosal trauma or minor oral aphthous ulcer: a randomized, double-blind, placebo-controlled, parallel-group, single-dose study. J Orofac Pain 25:327–332PubMed

38.

Akhionbare O, Ojehanon PI (2007) The Palliative Effects of Lidocaine with adrenaline on recurrent Aphthous Stomatitis (RAS). J Med Sci 7:860–864. https://doi.org/10.3923/jms.2007.860.864CrossRef

39.

Yamashita S, Sato S, Kakiuchi Y, Miyabe M, Yamaguchi H (2002) Lidocaine toxicity during frequent viscous lidocaine use for painful tongue ulcer. J Pain Symptom Manag 24(5):543–545. https://doi.org/10.1016/s0885-3924(02)00498-0CrossRef

40.

Al-Maweri SA, Alaizari N, Alanazi RH et al (2021) Efficacy of hyaluronic acid for recurrent aphthous stomatitis: a systematic review of clinical trials. Clin Oral Investig 25:6561–6570. https://doi.org/10.1007/s00784-021-04180-4CrossRefPubMed

41.

Suter VGA, Sjölund S, Bornstein MM (2017) Effect of laser on pain relief and wound healing of recurrent aphthous stomatitis: a systematic review. Lasers Med Sci 32:953–963. https://doi.org/10.1007/s10103-017-2184-zCrossRefPubMed

42.

Khademi H, Iranmanesh P, Moeini A, Tavangar A (2014) Evaluation of the effectiveness of the iralvex gel on the recurrent aphthous stomatitis management. Int Sch Res Notices 14:175378. https://doi.org/10.1155/2014/175378CrossRef

43.

Phillips KS, Carrillo Medina WC, Potter JM, Al-Eryani K, Enciso R (2019) Systematic review with meta-analyses of natural products in the treatment of recurrent aphthous stomatitis. Int J Oral Dent Health 5:103. https://doi.org/10.23937/2469-5734/1510103CrossRef

44.

Symoens J, Brugmans J (1974) Letter: treatment of recurrent aphthous stomatitis and herpes with levamisole. Br Med J 4:592. https://doi.org/10.1136/bmj.4.5944.592CrossRefPubMedPubMedCentral

45.

Olson JA, Silverman S Jr (1978) Double-blind study of levamisole therapy in recurrent aphthous stomatitis. J Oral Pathol 7:393–399. https://doi.org/10.1111/j.16000714.1978.tb01608.xCrossRefPubMed

46.

Weckx LL, Hirata CH, Abreu MA, Fillizolla VC, Silva OM (1992) Levamisole does not prevent lesions of recurrent aphthous stomatitis: a double-blind placebo-controlled clinical trial. Rev Assoc Méd Bras 55:132–138. https://doi.org/10.1590/s0104-42302009000200014CrossRef

47.

Femiano F, Gombos F, Scully C (2003) Recurrent aphthous stomatitis unresponsive to topical corticosteroids: a study of the comparative therapeutic effects of systemic prednisone and systemic sulodexide. Int J Dermatol 42:394–397. https://doi.org/10.1046/j.1365-4362.2003.01853.xCrossRefPubMed

48.

Volkov I, Rudoy I, Freud T, Sardal G, Naimer S, Peleg R, Press Y (2009) Effectiveness of vitamin B12 in treating recurrent aphthous stomatitis: a randomized, double-blind, placebo-controlled trial. J Am Board Fam Med 22:9–16. https://doi.org/10.3122/jabfm.2009.01.080113CrossRefPubMed

49.

Merchant HW, Gangarosa LP, Morse PK, Strain WH, Baisden C (1981) Zinc sulfate as a Preventive of recurrent aphthous ulcers. J Dent Res 60A:609–611

50.

Mimura MA, Hirota SK, Sugaya NN et al (2009) Systemic treatment in severe cases of recurrent aphthous stomatitis: an open trial. Clin (Sau Paulo) 64:193–198. https://doi.org/10.1590/s1807-59322009000300008CrossRef

51.

Robinson ND, Guitart J (2003) Recalcitrant, recurrent aphthous stomatitis treated with etanercept. Arch Derm 139:1259–1262. https://doi.org/10.1001/archderm.139.10.1259CrossRefPubMed

52.

Meghanadh KR, Kaur M, Haldipur D et al (2021) Rebamipide in Recurrent Aphthous Stomatitis: review of indian evidence. Indian Pract 74:30–35

53.

Parvathidevi MK, Ramesh DN, Shrinivas K, et.al (2014) Efficacy of rebamipide and levamisole in the treatment of patients with recurrent aphthous ulcer-a comparative study. J Clin Diagn Res 8(11):ZC119–Z122. https://doi.org/10.7860/JCDR/2014/10295.5202CrossRef

54.

Jadhav A, Marathe S, Mhapuskar A (2015) To evaluate the efficacy of rebamipide on clinical resolution and recurrence of minor recurrent aphthous stomatitis. Int J Dent Health Sci 2:781–797

55.

Hasan S, Perween N, Saeed S, Kaur M, Gombra V, Rai A (2020) Evaluation of 5% amlexenox oral paste and Rebamipide Tablets in treatment of recurrent apthous stomatitis and comparison with Dologel CT. Indian J Otolaryngol Head Neck Surg 27:1–7. https://doi.org/10.1007/s12070-020-01858-1CrossRef

56.

Uppalwar P, Kunjir G, Krishna Kumar R et al (2016) Comparison of therapeutic effect of topical Amlexanox (5%), and oral Rebamipide (100 mg) in the management of oral aphthous ulceration. J Oral Dent Health 2:6–8

57.

Li L, Gu H, Zhang G (2014) Association between recurrent aphthous stomatitis and Helicobacter pylori infection: a meta-analysis. Clin Oral Investig 18:1553–1560. https://doi.org/10.1007/s00784-014-1230-5CrossRefPubMed

58.

Gao Y, Gupta N, Abdalla M (2021) Recurrent aphthous stomatitis improved after eradication therapy for Helicobacter pylori. Case Rep Gastrointest Med 30:5543838. https://doi.org/10.1155/2021/5543838CrossRef

59.

Gallo CD, Mimura MA, Sugaya NN (2009) Psychological stress and recurrent aphthous stomatitis. Clinics 64:645–648. https://doi.org/10.1590/S1807-59322009000700007CrossRefPubMed

60.

Zakaria M, Hosny R (2018) Relation between salivary cortisol and alpha amylase levels and anxiety in egyptian patients with minor recurrent aphthous stomatitis. Egypt Dent J 64:1235–1243. https://doi.org/10.21608/edj.2018.77378CrossRef

Titel: Management of Recurrent Aphthous Stomatitis: An Indian Expert Consensus
verfasst von: Samir Bhargava
Satya Prakash Dubey
Deepak Haldipur
Bachi Hathiram
Charuhas Jagtap
Vicky Khattar
Shriram Vasant Kulkarni
Ashwin Kotamkar
Parthasarathy Muralidharan
Pradeep Kumar
Amit Qamra
Abhishek Ramadhin
Sreenivasan Venkatraman
Publikationsdatum: 28.03.2023
Verlag: Springer India
Erschienen in: Indian Journal of Otolaryngology and Head & Neck Surgery / Ausgabe 3/2023
Print ISSN: 2231-3796
Elektronische ISSN: 0973-7707
DOI: https://doi.org/10.1007/s12070-023-03708-2

Neu im Fachgebiet HNO

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Hörschwäche erhöht Demenzrisiko unabhängig von Beta-Amyloid

29.05.2024 Hörstörungen Nachrichten

Hört jemand im Alter schlecht, nimmt das Hirn- und Hippocampusvolumen besonders schnell ab, was auch mit einem beschleunigten kognitiven Abbau einhergeht. Und diese Prozesse scheinen sich unabhängig von der Amyloidablagerung zu ereignen.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Management of Recurrent Aphthous Stomatitis: An Indian Expert Consensus

Abstract

Neu im Fachgebiet HNO

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

Hörschwäche erhöht Demenzrisiko unabhängig von Beta-Amyloid

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

Update HNO

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2023

Ramsay Hunt Syndrome with Pharyngolaryngeal Involvement Mimicking Acute Stroke: A Case Report

Resolution of blood eosinophilia and limited mouth opening after short-term follow-up in a pediatric Langerhans cell histiocytosis case

An Audit of Tracheostomy in Traumatic Brain Injury

Unusual Case of a Foreign Body in Tracheo-Esophageal Party wall

The Presence of a Zygomatic Nerve Plexus in a Cadaveric Specimen Without a Zygomatic Branch of the Facial Nerve

Patterns of Distant Metastasis in Head and Neck Cancer in a Tertiary Care Centre

Neu im Fachgebiet HNO

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

Hörschwäche erhöht Demenzrisiko unabhängig von Beta-Amyloid

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

Update HNO